In this episode of the Enginears podcast, Faro Health CTO Patrick Leung discusses how the company is using AI to transform clinical trial protocol design, unlocking significant cost savings and operational efficiencies for drug developers. He explains Faro’s vision of moving away from static, document-based protocols toward a dynamic, data-driven approach that enables real-time feasibility assessments, cost modeling, and operational benchmarking.
Patrick shares the challenges and opportunities of applying AI in a heavily regulated, compliance-driven environment, and how Faro Health is leveraging AI agents to accelerate decision-making while maintaining quality and compliance. He also offers insights on improving large language model performance, building effective AI teams within life sciences, and where Faro is placing its strategic bets for the next 3–6 months.
The conversation closes with a look ahead at how AI-powered tools will reshape clinical trial operations, speed up drug development, and support the industry’s shift toward smarter, more patient-centric trials.
